Industry News
Pharmaceutical Industry News
Ogilvy Health’s new creative chief Hessel reflects on pharma’s pandemic opportunities
Ogilvy Health's new creative chief Hessel reflects on pharma's pandemic opportunities nmissakian Thu, 01/20/2022 - 22:25
Blueprint promotes two more execs to C-suite as it looks to realize Ayvakit’s potential
Blueprint promotes two more execs to C-suite as it looks to realize Ayvakit's potential kdunleavy Thu, 01/20/2022 - 11:12
Fierce JPM Week: AstraZeneca cancer R&D head marks Imfinzi as ‘core backbone’ of oncology strategy with the right combo—including treme
Fierce JPM Week: AstraZeneca cancer R&D head marks Imfinzi as 'core backbone' of oncology strategy with the right combo—including treme aliu Thu, 01/20/2022 - 10:00
Goodbye Humira, hello Dupixent: Sanofi and Regeneron outspend AbbVie to top 2021’s pharma TV ad spenders
Goodbye Humira, hello Dupixent: Sanofi and Regeneron outspend AbbVie to top 2021’s pharma TV ad spenders badams Thu, 01/20/2022 - 09:48
Viatris yanks one batch of diabetes med Semglee because of missing label risks
Viatris yanks one batch of diabetes med Semglee because of missing label risks fkansteiner Thu, 01/20/2022 - 09:41
Merck scores a win in $1.4B insurance fight over devastating cyberattack
Merck scores a win in $1.4B insurance fight over devastating cyberattack esagonowsky Thu, 01/20/2022 - 09:30
NantWorks founder Soon-Shiong plans vaccine plant in South Africa, pledges $6.5M to train workers
NantWorks founder Soon-Shiong plans vaccine plant in South Africa, pledges $6.5M to train workers jkeenan Thu, 01/20/2022 - 09:27
Merck’s Clyburn headed for the exit, opening top human health spot at the New Jersey pharma giant
Merck's Clyburn headed for the exit, opening top human health spot at the New Jersey pharma giant fkansteiner Thu, 01/20/2022 - 08:47
Doceree offers glimpse into trends of ‘programmatic marketing’
Doceree offers glimpse into trends of 'programmatic marketing' sharon.coey Thu, 01/20/2022 - 07:39
No deal for GSK consumer health: Unilever stops raising $68B bid amid investor pushback
No deal for GSK consumer health: Unilever stops raising $68B bid amid investor pushback aliu Thu, 01/20/2022 - 07:15
COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they’re a double-edged sword for J&J and AZ
COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ badams Thu, 01/20/2022 - 06:49
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors kdunleavy Thu, 01/20/2022 - 00:19
Fierce JPM Week: Novo Nordisk plans more patient outreach, doctor education as Wegovy launch works through supply woes
Fierce JPM Week: Novo Nordisk plans more patient outreach, doctor education as Wegovy launch works through supply woes esagonowsky Wed, 01/19/2022 - 12:51
Fierce JPM Week: Game recognizes game—Lilly, Novartis execs commend Pfizer on Paxlovid, but where does that leave them in the COVID market?
Fierce JPM Week: Game recognizes game—Lilly, Novartis execs commend Pfizer on Paxlovid, but where does that leave them in the COVID market? aarmstrong Wed, 01/19/2022 - 11:47
Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech
Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech jkeenan Wed, 01/19/2022 - 11:03
They Made the Most of the Opioid Crisis. Until They Didn’t.
In “The Hard Sell,” the journalist Evan Hughes tells the story of the rise and fall of Insys Therapeutics — and the larger pharmaceutical industry.
Searching for Pfizer’s Paxlovid Pills When Mom Got Covid
The experience showed how hard it is for many people to get potentially lifesaving treatments.
UCB buys rare disease drugmaker Zogenix for up to $1.9B, bolstering its epilepsy position
UCB buys rare disease drugmaker Zogenix for up to $1.9B, bolstering its epilepsy position aliu Wed, 01/19/2022 - 10:27
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme kdunleavy Wed, 01/19/2022 - 09:53
Did BMS set up a subsidiary to avoid paying $1.4B in U.S. taxes? The Senate finance chairman is on the case
Did BMS set up a subsidiary to avoid paying $1.4B in U.S. taxes? The Senate finance chairman is on the case esagonowsky Wed, 01/19/2022 - 09:41